Vimarsana
Biggest News Aggregation in the World

Page 2 - Kare Schultz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kare Schultz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kare Schultz Today - Breaking & Trending Today

3 No-Brainer Stocks to Buy With $20 Right Now - Vimarsana News

3 No-Brainer Stocks to Buy With $20 Right Now

You don't need a mountain of cash to begin building your wealth on Wall Street.

Source: fool.com
3 No-Brainer Stocks to Buy With $20 Right Now - Vimarsana News

3 No-Brainer Stocks to Buy With $20 Right Now

You don't need a boatload of cash to begin growing your wealth on Wall Street.

Source: fool.com
Teva seeks to reinvent itself as branded drug developer - Vimarsana News

Teva seeks to reinvent itself as branded drug developer

After years of shrinking revenue, new CEO Richard Francis is switching the emphasis to innovation. "Globes" looks at Teva's drug development pipeline.

Why did Teva fall 20% in April-May? - Vimarsana News

Why did Teva fall 20% in April-May?

An SEC filing reveals that major US-based shareholder Capital Research Global Investors sold its entire holding.

Teva targets growth through innovation - Vimarsana News

Teva targets growth through innovation

Teva's new strategy stresses growth through branded drugs and biosimilars. The company sees Austedo sales of $2.5 billion in 2027.